Opko Health Inc. buy melinda
Start price
27.11.17
/
50%
€4.20
Target price
28.05.18
€6.00
Performance (%)
-23.50%
End price
28.05.18
€3.21
Summary
This prediction ended on 28.05.18 with a price of €3.21. The price of Opko Health Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.50%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Opko Health Inc. | - | - | -33.189% | -10.756% |
| iShares Core DAX® | 0,46 % | -2,00 % | 9,98 % | 58,55 % |
| iShares Nasdaq 100 | -1,79 % | -5,74 % | -0,78 % | 80,51 % |
| iShares Nikkei 225® | 5,12 % | 9,09 % | 28,82 % | 62,78 % |
| iShares S&P 500 | -1,76 % | -3,67 % | -0,54 % | 54,39 % |
Comments by melinda for this prediction
In the thread Opko Health Inc. diskutieren
Pharmazeutische SecteurProduits Agenda 28/02 Ergebnisse Veröffentlichung
OPKO Health, Inc.
OPKO Health registriert seinen ersten Patienten in der Phase 2B von OPK88004 gutartiger Prostatahypertrophie zu behandeln
(Laufzeit überschritten)